Bronchial thermoplasty may improve asthma control up to 12 months after treatment

Ward, Neil
June 2007
Thorax;Jun2007, Vol. 62 Issue 6, p556
Academic Journal
The article discusses a study designed to assess the efficacy of bronchial thermoplasty up to 12 months after treatment. The patients had mild to severe asthma, were receiving treatment with inhaled corticosteroid and long-acting beta agonist inhalers. 56 of the 112 participants received treatments of bronchoscopic thermoplasty in addition to their usual therapy. After a year this group showed a significant reduction of their asthma symptoms.


Related Articles

  • Prescribing beta-agonists for respiratory disease. Scullion, Jane; Holmes, Steve // Independent Nurse;4/16/2010, p1 

    The article discusses about beta-agonists which are commonly prescribed to relieve symptoms of asthma & chronic obstructive pulmonary disease(COPD), focusing on the difference in its usage for both the diseases and the modes of action. After the initiation of inhaled corticosteroids(ICS), long...

  • Salbutamol eases COPD symptoms.  // Pulse;7/14/2003, Vol. 63 Issue 28, p13 

    Reports on the preference for beta agonists by patients with chronic obstructive pulmonary disease. Advantages of regular use of the drug.

  • Management of asthma in children. Townshend, J.; Hails, S.; Mckean, M. // BMJ: British Medical Journal (International Edition);8/4/2007, Vol. 335 Issue 7613, p253 

    The article presents an overview of the management of asthma in children. A discussion of what the acute managemnt of asthma, long term management of atopic asthma and episodic viral wheeze is is presented. The benefits and disadvantages of the use of corticosteroids and long acting beta...

  • CONFERENCE ROUND-UP.  // Pulse;12/9/2009, Vol. 69 Issue 39, p11 

    The article offers news briefs related to researches on diseases in Great Britain. A study in reveals that a fixed dose of dabigatran is as effective and safe as titrated warfarin following an acute venous thromboembolism. Another study examines that chronic obstructive pulmonary disease (COPD)...

  • Restriction of LABA use to combination ICS/LABA inhaler therapy in asthma. Beasley, Richard; Fingleton, James; Weatherall, Mark // Thorax;Feb2013, Vol. 68 Issue 2, p119 

    The author discusses the recommendation made by the British asthma guidelines in 2011 regarding the use of long acting beta agonists (LABAs) in the treatment of asthma. He mentions that LABAs might increase the risk of asthma mortality when used in fixed dose combination inhaled corticosteroid...

  • Four in five asthma deaths may be due to long acting β agonists. Hagan, Pat // BMJ: British Medical Journal (International Edition);6/24/2006, Vol. 332 Issue 7556, p1467 

    The article discusses the results of a study which suggests that eighty per cent of asthma-related deaths in the United States may be due to long acting β agonists. Details of the study and its findings are provided. Long acting β agonists, such as salmeterol and formoterol, are examined.

  • Changes in recommended treatments for mild and moderate asthma. Redding, Gregory J.; Stoloff, Stuart W. // Journal of Family Practice;Sep2004, Vol. 53 Issue 9, p692 

    This article reviews the 2002 National Asthma Education and Prevention Program (NAEPP) recommendations for the use of controlled medications for asthma, including the relative effectiveness of inhaled corticosteroids (ICSs) versus other controller medications, safety of long-term ICS use in...

  • Efficacy and Safety of Budesonide and Formoterol in One Pressurised Metered-Dose Inhaler in Adults and Adolescents with Moderate to Severe Asthma. Noonan, Michael; Rosenwasser, Lanny J.; Martin, Paula; O'Brien, Christopher D.; O'Dowd, Liza // Drugs;2006, Vol. 66 Issue 17, p2235 

    Background: Inhaled corticosteroids (ICSs) are the preferred maintenance therapy for adults and children with mild, moderate and severe persistent asthma, with the addition of a long-acting β2-adrenoceptor agonist to ICS therapy recommended for patients with moderate or severe persistent...

  • Gly/Gly and Arg/Arg genotype responses to albuterol differed in mild asthma.  // ACP Journal Club;Mar/Apr2005, Vol. 142 Issue 2, p43 

    The article cites a study which discusses the use of regularly scheduled albuterol treatment in asthma. The study was published in the 2004 issue of the journal "Lancet." In mild asthma, patients with the Gly/Gly genotype had better asthma control with albuterol than when it was withdrawn, and...


Read the Article


Sign out of this library

Other Topics